跳至主要内容
临床试验/DRKS00020453
DRKS00020453已完成未知

Pilot study for individualized remission induction of type 2 diabetes - PiREM

Klinikum der Universität München, Campus Innenstadt0 个研究点目标入组 8 人开始时间: 2020年1月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 64 Years(—)
性别
All

入选标准

  • T2D diagnosed within the last 6 years. T2D diagnosis confirmed by at least two different tests [HbA1c = 6.5% and (fasting glucose = 126 mg/dl or random glucose = 200 mg/dl or 2-h glucose in an oral glucose tolerance test = 200 mg/dl)]
  • Diabetic continuous glucose profile at study inclusion (at least two timepoints with fasting sensor glucose = 126 mg/dl or any sensor glucose value = 200 mg/dl; interruption of the antidiabetic medication, if necessary, for 1-7 days)
  • Written informed consent

排除标准

  • Other diabetes type than type 2
  • Pregnancy or planned pregnancy in the following 12 months
  • Planned surgery in the following 12 months
  • eGFR < 30 ml/min/1.73 m²
  • Myocardial infarction or stroke within the last 6 months
  • Heart failure = NYHA 2
  • Previous or planned bariatric surgery
  • Psychiatric disorder requiring inpatient treatment within the last 12 months
  • Alcohol abuse or use of illegal drugs
  • Other disease that prevents participation in the planned lifestyle intervention
  • Participation in another clinical trial

研究者

发起方
Klinikum der Universität München, Campus Innenstadt

相似试验

Pilot study for individualized remission induction... | 临床试验